Big pharma allegedly paid Russian middlemen for state drug supplies

Four major drugmakers reportedly paid tens of millions of dollars to intermediaries to supply medicines to Russian government entities, potentially circumventing sanctions. The claim is sourced from an investigation, with details on companies and amounts unverified. This could expose firms to legal and reputational risk and signal sanctions enforcement gaps.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works